Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Year in Review
  • Published:

Inflammation in 2017

Connectivity to other fields brings new ideas

Multiple scientific fields pertaining to inflammation, including the fields of cardiovascular, infection and cancer research, are increasingly contributing to our understanding of rheumatoid arthritis (RA). In 2017, such research has helped develop our understanding of RA comorbidity, the link between RA pathogenesis and infection, and the effects of new therapies.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Contributions from the cardiovascular, infection and cancer fields to the rheumatoid arthritis field.

References

  1. Ridker, P. M. et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N. Engl. J. Med. 377, 1119–1131 (2017).

    Article  CAS  Google Scholar 

  2. Dutzan, N. et al. On-going mechanical damage from mastication drives homeostatic Th17 cell responses at the oral barrier. Immunity 46, 133–147 (2017).

    Article  CAS  Google Scholar 

  3. Belkhir, R. et al. Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor treatment. Ann. Rheum. Dis. 76, 1747–1750 (2017).

    Article  CAS  Google Scholar 

  4. Hong, S. S. et al. PUMA gene delivery to synoviocytes reduces inflammation and degeneration of arthritic joints. Nat. Commun. 8, 146 (2017).

    Article  Google Scholar 

  5. Robertson, J. et al. Interleukin-6 blockade raises LDL via reduced catabolism rather than via increased synthesis: a cytokine-specific mechanism for cholesterol changes in rheumatoid arthritis. Ann. Rheum. Dis. 76, 1949–1952 (2017).

    Article  CAS  Google Scholar 

  6. Hot, A., Lavocat, F., Lenief, V. & Miossec, P. Simvastatin inhibits the pro-inflammatory and pro-thrombotic effects of IL-17 and TNF-α on endothelial cells. Ann. Rheum. Dis. 72, 754–760 (2013).

    Article  CAS  Google Scholar 

  7. Miossec, P., Cavender, D. & Ziff, M. Production of interleukin 1 by human endothelial cells. J. Immunol. 136, 2486–2491 (1986).

    CAS  PubMed  Google Scholar 

  8. Ridker, P. M. et al. Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial. Lancet 390, 1833–1842 (2017).

    Article  CAS  Google Scholar 

  9. Pfeifle, R. et al. Regulation of autoantibody activity by the IL-23-TH17 axis determines the onset of autoimmune disease. Nat. Immunol. 18, 104–113 (2017).

    Article  CAS  Google Scholar 

  10. Yamanishi, Y. et al. Regional analysis of p53 mutations in rheumatoid arthritis synovium. Proc. Natl Acad. Sci. USA 99, 10025–10030 (2002).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The work of the author has been supported by the OpeRa IHU programme and the Institut Universitaire de France. P.M. is a senior member of the Institut Universitaire de France.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pierre Miossec.

Ethics declarations

Competing interests

The author declares no competing financial interests.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Miossec, P. Connectivity to other fields brings new ideas. Nat Rev Rheumatol 14, 65–66 (2018). https://doi.org/10.1038/nrrheum.2017.215

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrrheum.2017.215

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer